VEGFA may be a potential marker of myopic choroidal thickness and vascular density changes [PDF]
Scientific ReportsTo evaluate the changes of choroidal thickness (CT) and blood flow related to myopia, and its effects of vascular endothelial growth factor (VEGFA) on choroidal vessels in myopia.
Ting Wan +5 more
doaj +2 more sources
Clinical efficacy and changes of serum VEGF-A, VEGF-B, and PLGF after conbercept treating neovascular age-related macular degeneration [PDF]
International Journal of Ophthalmology, 2023 AIM: To evaluate the clinical efficacy and systemic safety profile of conbercept in clinical practice on vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental growth factor (PLGF) levels after intravitreal injections for the neovascular age ...
Xiao-Dong Chen +5 more
doaj +1 more source
Efficacy and safety of intravitreal conbercept and triamcinolone acetonide for wet age-related macular degeneration in China: a meta-analysis. [PDF]
Int OphthalmolYang F, Hu R.
europepmc +3 more sources
Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II. [PDF]
BMC PediatrYang XM, Li QP, Wang ZH, Zhang MN.
europepmc +3 more sources
Proteomic analysis of anti-angiogenic effects by conbercept in the mice with oxygen induced retinopathy [PDF]
International Journal of Ophthalmology, 2020 AIM: To analyze the retinal proteomes with and without conbercept treatments in mice with oxygen-induced retinopathy (OIR) and identify proteins involved in the molecular mechanisms mediated by conbercept.
Ji Jin +3 more
doaj +1 more source
Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept. [PDF]
BMC OphthalmolMa Y, Rao S, Tan Y, Du H, Sun X.
europepmc +3 more sources
Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo. [PDF]
PLoS ONE, 2013 VEGF family factors are known to be the principal stimulators of abnormal angiogenesis, which play a fundamental role in tumor and various ocular diseases. Inhibition of VEGF is widely applied in antiangiogenic therapy.
Qin Wang +6 more
doaj +1 more source
Conbercept Versus Conbercept Combined with Retinal Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion [PDF]
, 2021 Abstract Background: To evaluate the efficacy of intravitreal injection of conbercept (IVC) with or without laser photocoagulation for recurrent macular edema secondary to branch retinal vein occlusion (BRVO). Methods: 82 patients (82 eyes) with recurrent macular edema secondary to BRVO were collected.
Gengmin Tong +3 more
openaire +1 more source
Systematic Reviews, 2021 Background The comparative safety and efficacy between anti-vascular endothelial growth factor agents (anti-VEGFs) and between combined therapies for patients with neovascular age-related macular degeneration (nAMD) is unclear.
Andrea C. Tricco +17 more
doaj +1 more source
Effect of subconjunctival injection with conbercept as an adjuvant to filtration surgery for open angle glaucoma: a prospective randomized interventional 6-month follow-up study [PDF]
International Journal of Ophthalmology, 2019 AIM: To compare the safety and efficacy of subconjunctival injection with conbercept and 5-fluorouracil (5-FU) for open angle glaucoma (OAG) patients after filtration surgery.
Jing Zhang +6 more
doaj +1 more source